Prospective Randomized Evaluation of a Collagen/Thrombin and Autologous Platelet Hemostatic Agent During Total Knee Arthroplasty

Journal of Arthroplasty

Volumn 27, Issue 5, 2012, Pages 695-702

  Bloomfield, Michael R ^a   Klika, Alison K ^a   Molloy, Robert M ^a   Froimson, Mark I ^a   Krebs, Viktor E ^a   Barsoum, Wael K ^a  

^a LERNER RESEARCH INSTITUTE   (United States)

Author keywords

Blood conservation; Platelet rich plasma; Thrombin; Total knee arthroplasty; Vitagel

Indexed keywords

ACETYLSALICYLIC ACID; ANTIBIOTIC AGENT; AUTOLOGOUS PLATELET HEMOSTATIC AGENT; COLLAGEN; ENOXAPARIN; HEMOSTATIC AGENT; NARCOTIC ANALGESIC AGENT; THROMBIN; UNCLASSIFIED DRUG;

ADULT; AGED; ANTIBIOTIC THERAPY; ARTICLE; CLINICAL ASSESSMENT; CONTROLLED STUDY; DEEP VEIN THROMBOSIS; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; FEMALE; FLUID THERAPY; HEMOSTASIS; HUMAN; KNEE ARTHRITIS; KNEE OSTEOARTHRITIS; MAJOR CLINICAL STUDY; MALE; POSTOPERATIVE HEMORRHAGE; POSTOPERATIVE PAIN; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL; SKIN ABSCESS; STANDARD; SURGICAL TECHNIQUE; THROMBOCYTE TRANSFUSION; TOTAL KNEE REPLACEMENT; TREATMENT OUTCOME; VENOUS THROMBOEMBOLISM;

AGED; AGED, 80 AND OVER; ARTHROPLASTY, REPLACEMENT, KNEE; COLLAGEN; DOUBLE-BLIND METHOD; FEMALE; HEMOSTASIS, SURGICAL; HUMANS; MALE; MIDDLE AGED; POSTOPERATIVE HEMORRHAGE; PROSPECTIVE STUDIES; THROMBIN;

EID: 84859886362     PISSN: 08835403     EISSN: 15328406     Source Type: Journal    
DOI: 10.1016/j.arth.2011.09.014     Document Type: Article

References (37)

1. Berman A.T., Geissele A.E., Bosacco S.J. Blood loss with total knee arthroplasty. Clin Orthop Relat Res 1988, 234:137.
2. Cushner F.D., Friedman R.J. Blood loss in total knee arthroplasty. Clin Orthop Relat Res 1991, 269:98.
3. Bierbaum B.E., Callaghan J.J., Galante J.O., et al. An analysis of blood management in patients having a total hip or knee arthroplasty. J Bone Joint Surg Am 1999, 8:2.
4. Stramer S.L. Current risks of transfusion-transmitted agents: a review. Arch Pathol Lab Med 2007, 131:702.
5. Bridgens J.P., Evans C.R., Dobson P.M., et al. Intraoperative red blood-cell salvage in revision hip surgery. A case-matched study. J Bone Joint Surg Am 2007, 89:270.
6. Kendall S.J., Weir J., Aspinall R., et al. Erythrocyte transfusion causes immunosuppression after total hip replacement. Clin Orthop Relat Res 2000, 381:145.
7. Murphy P., Heal J.M., Blumberg N. Infection or suspected infection after hip replacement surgery with autologous or homologous blood transfusions. Transfusion 1991, 31:212.
8. Hill G.E., Frawley W.H., Griffith K.E., et al. Allogeneic blood transfusion increases the risk of postoperative bacterial infection: a meta-analysis. J Trauma 2003, 54:908.
9. Hannon T. The contemporary economics of transfusions. Perioperative transfusion medicne 2006, 13. Lippincott Williams & Wilkins. 2nd ed. B. Spiess, R. Spence, A. Shander (Eds.).
10. Goodnough L.T., Bodner M.S., Martin J.W. Blood transfusion and blood conservation: cost and utilization issues. Am J Med Qual 1994, 9:172.
11. Thoms R.J., Marwin S.E. The role of fibrin sealants in orthopaedic surgery. J Am Acad Orthop Surg 2009, 17:727.
12. US Food and Drug Administration Vitagel™ Surgical Hemostat-P050044. Last accessed February 3, 2011. http://www.fda.gov/MedicalDevices/ProductsandMedicalProcedures/DeviceApprovalsandClearances/Recently-ApprovedDevices/ucm078128.htm.
13. Sherman R., Chapman W.C., Hannon G., et al. Control of bone bleeding at the sternum and iliac crest donor sites using a collagen-based composite combined with autologous plasma: results of a randomized controlled trial. Orthopedics 2001, 24:137.
14. The CoStasis Multi-center Collaborative Writing Committee A novel collagen-based composite offers effective hemostasis for multiple surgical indications: results of a randomized controlled trial. Surgery 2001, 129:445.
15. Thibodeaux K.T., Lorio M.P., Block J.E. Intraoperative hemostasis during spinal reconstructive procedures. Orthopedics 2003, 26:413.
16. Buncke G.M., Sherman R. CoStasis provides superior control of diffuse bleeding at muscle-flap donor sites, compared to manual compression. J Reconstr Microsurg 2000, 16:557.
17. Chapman W.C., Wren S.M., Lebovic G.S., et al. Effective management of bleeding during tumor resection witha collagen-based hemostatic agent. Am Surg 2002, 68:802.
18. Rosneck J., Klika A., Barsoum W. The effectiveness of TissueLink's hemosealing technology during THA 2007.
19. Schulz K.F., Altman D.G., Moher D. CONSORT 2010 statement: updated guidelines for reporting parallel group randomized trials. Ann Intern Med 2010, 152:726.
20. Johanson N.A., Lachiewicz P.F., Lieberman J.R., et al. American academy of orthopaedic surgeons clinical practice guideline on prevention of symptomatic pulmonary embolism in patients undergoing total hip or knee arthroplasty. J Bone Joint Surg Am 2009, 91:1756.
21. Good L., Peterson E., Lisander B. Tranexamic acid decreases external blood loss but not hidden blood loss in total knee replacement. Br J Anaesth 2003, 90:596.
22. Nadler S., Hidalgo J., Block T. Prediction of blood volume in normal human adults. Surgery 1962, 51:224.
23. Klika A., Gehrig M., Boukis L., et al. A rapid recovery program after total knee arthroplasty. Seminars in Arthroplasty 2009, 20:40.
24. Lew W.K., Weaver F.A. Clinical use of topical thrombin as a surgical hemostat. Biologics 2008, 2:593.
25. Lawson J.H. The clinical use and immunologic impact of thrombin in surgery. Semin Thromb Hemost 2006, 32(Suppl 1):98.
26. Bowman L.J., Anderson C.D., Chapman W.C. Topical recombinant human thrombin in surgical hemostasis. Semin Thromb Hemost 2010, 36:477.
27. Orthovita Vitagel Surgical Hemostat: instructions for use Last accessed February 3, 2011. http://www.orthovita.com/vitagel/files/Vitagel_Hemostat_InstructionsForUse.pdf.
28. Carruthers J., Carruthers A. Mad cows, prions, and wrinkles. Arch Dermatol 2002, 138:667.
29. Hall M.P., Band P.A., Meislin R.J., et al. Platelet-rich plasma: current concepts and application in sports medicine. J Am Acad Orthop Surg 2009, 17:602.
30. Arnoczky S., Caballero O., Yeni Y. On the horizon from the ORS. J Am Acad Orthop Surg 2010, 18:448.
31. Everts P.A., Devilee R.J., Brown Mahoney C., et al. Platelet gel and fibrin sealant reduce allogeneic blood transfusions in total knee arthroplasty. Acta Anaesthesiol Scand 2006, 50:593.
32. Esler C.N., Blakeway C., Fiddian N.J. The use of a closed-suction drain in total knee arthroplasty. A prospective, randomised study. J Bone Joint Surg Br 2003, 85:215.
33. Gardner M.J., Demetrakopoulos D., Klepchick P.R., et al. The efficacy of autologous platelet gel in pain control and blood loss in total knee arthroplasty. An analysis of the haemoglobin, narcotic requirement and range of motion. Int Orthop 2007, 31:309.
34. Peerbooms J.C., de Wolf G.S., Colaris J.W., et al. No positive effect of autologous platelet gel after total knee arthroplasty. Acta Orthop 2009, 80:557.
35. Levy O., Martinowitz U., Oran A., et al. The use of fibrin tissue adhesive to reduce blood loss and the need for blood transfusion after total knee arthroplasty. A prospective, randomized, multicenter study. J Bone Joint Surg Am 1999, 81:1580.
36. Geerts W.H., Bergqvist D., Pineo G.F., et al. Prevention of venous thromboembolism: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th edition). Chest 2008, 133:381S.
37. Krebs V.E., Higuera C., Barsoum W.K., et al. Blood management in joint replacement surgery: what's in and what's out. Orthopedics 2006, 29:801.